Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer.
Mountzios I, Bournakis E, Efstathiou E, Varkaris A, Wen S, Chrisofos M, Deliveliotis C, Alamanis C, Anastasiou I, Constantinides C, Karadimou A, Tsiatas M, Papadimitriou C, Bamias A, Dimopoulos MA.
Mountzios I, et al.
Urology. 2011 Mar;77(3):682-7. doi: 10.1016/j.urology.2010.08.044. Epub 2011 Jan 22.
Urology. 2011.
PMID: 21256546